中药生物活性胶囊化纳米制剂治疗胃癌:简要综述

IF 2.5 4区 材料科学 Q3 MATERIALS SCIENCE, MULTIDISCIPLINARY Nano Futures Pub Date : 2023-09-08 DOI:10.1088/2399-1984/acf822
Arya Rai̇, Simrandeep Kaur, S. Rawat, Inderbir Singh
{"title":"中药生物活性胶囊化纳米制剂治疗胃癌:简要综述","authors":"Arya Rai̇, Simrandeep Kaur, S. Rawat, Inderbir Singh","doi":"10.1088/2399-1984/acf822","DOIUrl":null,"url":null,"abstract":"Gastric cancer is a prominent cause of death globally. The major risk factors responsible for its development include age, H. pylori infection, excessive salt intake, and lack of fruits and vegetables in the diet. It is diagnosed using ultrasound, CT scan, endoscopic biopsy, and by detection of certain biomarkers. The conventional therapies for treatment of gastric cancer include the use of radiations, surgical resection, and chemotherapy. However, there are certain major issues associated with these treatments, like high risk of tumour reoccurrence, drug resistance development, less bioavailability of the drug at target site, rapid drug metabolism and high systemic toxicity due to drug doses. All such limitations of conventional treatments can be overcome with the use of herbal bio-actives as they exhibit less toxicity to normal healthy cells and reduce the risk of tumour recurrence and resistance development. Nano-formulations are developed to aid in targeted drug delivery, and to enhance the solubility, stability, bioavailability, and therapeutic efficacy of phytoconstituents. With the emergence of nanomaterials, different imaging modalities have been integrated into one single platform, and combined therapies with synergetic effects against gastric cancer were established. Moreover, the development of theragnostic strategies with simultaneous diagnostic and therapeutic ability was boosted by multifunctional nanoparticles. The present review discusses about the gastric cancer including its mortality rate, secular trends, pathophysiology, etiology, risk factors, diagnosis, and different treatment approaches with major emphasis on herbal bioactives (quercetin, paclitaxel, resveratrol, curcumin and ginsenosides) and different herbal constituent encapsulated nano-formulations (such as nanoparticles, niosomes, liposomes, nano-emulsion, and micelles). Challenges and future prospects of herbal bioactive encapsulated nano-formulations for the treatment/management of gastric cancers has been included in the later part of the manuscript.","PeriodicalId":54222,"journal":{"name":"Nano Futures","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Herbal bioactive encapsulated nano-formulations for the treatment of gastric cancer: a concise review\",\"authors\":\"Arya Rai̇, Simrandeep Kaur, S. Rawat, Inderbir Singh\",\"doi\":\"10.1088/2399-1984/acf822\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gastric cancer is a prominent cause of death globally. The major risk factors responsible for its development include age, H. pylori infection, excessive salt intake, and lack of fruits and vegetables in the diet. It is diagnosed using ultrasound, CT scan, endoscopic biopsy, and by detection of certain biomarkers. The conventional therapies for treatment of gastric cancer include the use of radiations, surgical resection, and chemotherapy. However, there are certain major issues associated with these treatments, like high risk of tumour reoccurrence, drug resistance development, less bioavailability of the drug at target site, rapid drug metabolism and high systemic toxicity due to drug doses. All such limitations of conventional treatments can be overcome with the use of herbal bio-actives as they exhibit less toxicity to normal healthy cells and reduce the risk of tumour recurrence and resistance development. Nano-formulations are developed to aid in targeted drug delivery, and to enhance the solubility, stability, bioavailability, and therapeutic efficacy of phytoconstituents. With the emergence of nanomaterials, different imaging modalities have been integrated into one single platform, and combined therapies with synergetic effects against gastric cancer were established. Moreover, the development of theragnostic strategies with simultaneous diagnostic and therapeutic ability was boosted by multifunctional nanoparticles. The present review discusses about the gastric cancer including its mortality rate, secular trends, pathophysiology, etiology, risk factors, diagnosis, and different treatment approaches with major emphasis on herbal bioactives (quercetin, paclitaxel, resveratrol, curcumin and ginsenosides) and different herbal constituent encapsulated nano-formulations (such as nanoparticles, niosomes, liposomes, nano-emulsion, and micelles). Challenges and future prospects of herbal bioactive encapsulated nano-formulations for the treatment/management of gastric cancers has been included in the later part of the manuscript.\",\"PeriodicalId\":54222,\"journal\":{\"name\":\"Nano Futures\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2023-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nano Futures\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1088/2399-1984/acf822\",\"RegionNum\":4,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MATERIALS SCIENCE, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano Futures","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1088/2399-1984/acf822","RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

癌症是全球死亡的主要原因。导致其发展的主要风险因素包括年龄、幽门螺杆菌感染、过量摄入盐以及饮食中缺乏水果和蔬菜。它是通过超声波、CT扫描、内镜活检和某些生物标志物的检测来诊断的。癌症的常规治疗方法包括放射治疗、手术切除和化疗。然而,这些治疗存在一些主要问题,如肿瘤复发风险高、耐药性发展、药物在靶点的生物利用度低、药物代谢快以及药物剂量引起的高全身毒性。使用草药生物活性物质可以克服传统治疗的所有这些局限性,因为它们对正常健康细胞的毒性较小,并降低了肿瘤复发和耐药性发展的风险。开发纳米制剂是为了帮助靶向药物递送,并提高植物成分的溶解度、稳定性、生物利用度和治疗效果。随着纳米材料的出现,不同的成像模式被整合到一个单一的平台中,并建立了对癌症具有协同效应的联合疗法。此外,多功能纳米颗粒促进了具有同时诊断和治疗能力的诊断策略的发展。本文就癌症的死亡率、长期趋势、病理生理学、病因、危险因素、诊断、预后等方面进行综述,以及不同的治疗方法,主要侧重于草药生物活性物质(槲皮素、紫杉醇、白藜芦醇、姜黄素和人参皂苷)和不同的草药成分包封的纳米制剂(如纳米颗粒、niosomes、脂质体、纳米乳液和胶束)。草药生物活性包封纳米制剂用于治疗/管理胃癌的挑战和未来前景已包含在手稿的后面部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Herbal bioactive encapsulated nano-formulations for the treatment of gastric cancer: a concise review
Gastric cancer is a prominent cause of death globally. The major risk factors responsible for its development include age, H. pylori infection, excessive salt intake, and lack of fruits and vegetables in the diet. It is diagnosed using ultrasound, CT scan, endoscopic biopsy, and by detection of certain biomarkers. The conventional therapies for treatment of gastric cancer include the use of radiations, surgical resection, and chemotherapy. However, there are certain major issues associated with these treatments, like high risk of tumour reoccurrence, drug resistance development, less bioavailability of the drug at target site, rapid drug metabolism and high systemic toxicity due to drug doses. All such limitations of conventional treatments can be overcome with the use of herbal bio-actives as they exhibit less toxicity to normal healthy cells and reduce the risk of tumour recurrence and resistance development. Nano-formulations are developed to aid in targeted drug delivery, and to enhance the solubility, stability, bioavailability, and therapeutic efficacy of phytoconstituents. With the emergence of nanomaterials, different imaging modalities have been integrated into one single platform, and combined therapies with synergetic effects against gastric cancer were established. Moreover, the development of theragnostic strategies with simultaneous diagnostic and therapeutic ability was boosted by multifunctional nanoparticles. The present review discusses about the gastric cancer including its mortality rate, secular trends, pathophysiology, etiology, risk factors, diagnosis, and different treatment approaches with major emphasis on herbal bioactives (quercetin, paclitaxel, resveratrol, curcumin and ginsenosides) and different herbal constituent encapsulated nano-formulations (such as nanoparticles, niosomes, liposomes, nano-emulsion, and micelles). Challenges and future prospects of herbal bioactive encapsulated nano-formulations for the treatment/management of gastric cancers has been included in the later part of the manuscript.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nano Futures
Nano Futures Chemistry-General Chemistry
CiteScore
4.30
自引率
0.00%
发文量
35
期刊介绍: Nano Futures mission is to reflect the diverse and multidisciplinary field of nanoscience and nanotechnology that now brings together researchers from across physics, chemistry, biomedicine, materials science, engineering and industry.
期刊最新文献
Nanobiohybrids and bacterial carriers: a novel pathway to targeted cancer therapy The use of orthogonal analytical approaches to profile lipid nanoparticle physicochemical attributes Navigating the frontiers of graphene quality control to enable product optimisation and market confidence Overlapping top gate electrodes based on low temperature atomic layer deposition for nanoscale ambipolar lateral junctions Roadmap for unconventional computing with nanotechnology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1